Stressful manipulations that elevate corticosterone reduce blood-brain barrier permeability to pyridostigmine in the rat

Christopher M. Sinton, Thomas E. Fitch, Frederick Petty, Robert W. Haley

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Pyridostigmine bromide (PB), a reversible inhibitor of acetylcholinesterase (ACHE), is used for the treatment of myasthenia gravis. PB has also been provided to military personnel for preexposure protection against potential soman release. The entry of PB into the brain is typically minimal, but recently published data in mice suggest that a brief forced swim stress increases the permeability of the blood-brain barrier to PB. From these results, PB administered under stressful conditions was proposed to induce long-lasting central cholinergic deficits, potentially explaining the neurological and neuropsychological symptoms presented by some Gulf War veterans. In undertaking to replicate these results in the Long-Evans rat, no evidence of a stress-potentiated central effect of PB, administered at doses up 5.0 mg/kg ip, was found. Three stress protocols were used: restraint, forced swim, or a combined restraint/forced swim. Wistar rats were also tested in some of the protocols to ensure that the results were generalizable across rat strains, and plasma corticosterone levels were measured to test the effectiveness of the stressors employed. In contrast to the previously reported findings in the mouse, stress significantly reduced the entry of PB into rat brain, as measured by reduced inhibition of AChE activity: a 12.5% reduction in whole brain AChE activity after treatment with 5.0 mg/kg PB under control conditions declined to 9% after stress exposure. It is apparent, therefore, that the interaction between stress and PB requires further study, and previous data should be reassessed before they are used as a basis for interpreting symptoms presented by veterans. (C) 2000 Academic Press.

Original languageEnglish (US)
Pages (from-to)99-105
Number of pages7
JournalToxicology and Applied Pharmacology
Volume165
Issue number1
DOIs
StatePublished - May 15 2000

Fingerprint

Pyridostigmine Bromide
Corticosterone
Blood-Brain Barrier
Rats
Permeability
Brain
Veterans
Gulf War
Soman
Long Evans Rats
Myasthenia Gravis
Cholinesterase Inhibitors
Military Personnel
Cholinergic Agents
Wistar Rats
Personnel
Plasmas

Keywords

  • Acetylcholinesterase
  • Blood-brain barrier permeability
  • Corticosterone
  • Physostigmine hemisulfate
  • Pyridostigmine bromide
  • Restraint stress
  • Swim stress

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

Stressful manipulations that elevate corticosterone reduce blood-brain barrier permeability to pyridostigmine in the rat. / Sinton, Christopher M.; Fitch, Thomas E.; Petty, Frederick; Haley, Robert W.

In: Toxicology and Applied Pharmacology, Vol. 165, No. 1, 15.05.2000, p. 99-105.

Research output: Contribution to journalArticle

@article{276dab67f50b4fa084094da1c61a6535,
title = "Stressful manipulations that elevate corticosterone reduce blood-brain barrier permeability to pyridostigmine in the rat",
abstract = "Pyridostigmine bromide (PB), a reversible inhibitor of acetylcholinesterase (ACHE), is used for the treatment of myasthenia gravis. PB has also been provided to military personnel for preexposure protection against potential soman release. The entry of PB into the brain is typically minimal, but recently published data in mice suggest that a brief forced swim stress increases the permeability of the blood-brain barrier to PB. From these results, PB administered under stressful conditions was proposed to induce long-lasting central cholinergic deficits, potentially explaining the neurological and neuropsychological symptoms presented by some Gulf War veterans. In undertaking to replicate these results in the Long-Evans rat, no evidence of a stress-potentiated central effect of PB, administered at doses up 5.0 mg/kg ip, was found. Three stress protocols were used: restraint, forced swim, or a combined restraint/forced swim. Wistar rats were also tested in some of the protocols to ensure that the results were generalizable across rat strains, and plasma corticosterone levels were measured to test the effectiveness of the stressors employed. In contrast to the previously reported findings in the mouse, stress significantly reduced the entry of PB into rat brain, as measured by reduced inhibition of AChE activity: a 12.5{\%} reduction in whole brain AChE activity after treatment with 5.0 mg/kg PB under control conditions declined to 9{\%} after stress exposure. It is apparent, therefore, that the interaction between stress and PB requires further study, and previous data should be reassessed before they are used as a basis for interpreting symptoms presented by veterans. (C) 2000 Academic Press.",
keywords = "Acetylcholinesterase, Blood-brain barrier permeability, Corticosterone, Physostigmine hemisulfate, Pyridostigmine bromide, Restraint stress, Swim stress",
author = "Sinton, {Christopher M.} and Fitch, {Thomas E.} and Frederick Petty and Haley, {Robert W.}",
year = "2000",
month = "5",
day = "15",
doi = "10.1006/taap.2000.8931",
language = "English (US)",
volume = "165",
pages = "99--105",
journal = "Toxicology and Applied Pharmacology",
issn = "0041-008X",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Stressful manipulations that elevate corticosterone reduce blood-brain barrier permeability to pyridostigmine in the rat

AU - Sinton, Christopher M.

AU - Fitch, Thomas E.

AU - Petty, Frederick

AU - Haley, Robert W.

PY - 2000/5/15

Y1 - 2000/5/15

N2 - Pyridostigmine bromide (PB), a reversible inhibitor of acetylcholinesterase (ACHE), is used for the treatment of myasthenia gravis. PB has also been provided to military personnel for preexposure protection against potential soman release. The entry of PB into the brain is typically minimal, but recently published data in mice suggest that a brief forced swim stress increases the permeability of the blood-brain barrier to PB. From these results, PB administered under stressful conditions was proposed to induce long-lasting central cholinergic deficits, potentially explaining the neurological and neuropsychological symptoms presented by some Gulf War veterans. In undertaking to replicate these results in the Long-Evans rat, no evidence of a stress-potentiated central effect of PB, administered at doses up 5.0 mg/kg ip, was found. Three stress protocols were used: restraint, forced swim, or a combined restraint/forced swim. Wistar rats were also tested in some of the protocols to ensure that the results were generalizable across rat strains, and plasma corticosterone levels were measured to test the effectiveness of the stressors employed. In contrast to the previously reported findings in the mouse, stress significantly reduced the entry of PB into rat brain, as measured by reduced inhibition of AChE activity: a 12.5% reduction in whole brain AChE activity after treatment with 5.0 mg/kg PB under control conditions declined to 9% after stress exposure. It is apparent, therefore, that the interaction between stress and PB requires further study, and previous data should be reassessed before they are used as a basis for interpreting symptoms presented by veterans. (C) 2000 Academic Press.

AB - Pyridostigmine bromide (PB), a reversible inhibitor of acetylcholinesterase (ACHE), is used for the treatment of myasthenia gravis. PB has also been provided to military personnel for preexposure protection against potential soman release. The entry of PB into the brain is typically minimal, but recently published data in mice suggest that a brief forced swim stress increases the permeability of the blood-brain barrier to PB. From these results, PB administered under stressful conditions was proposed to induce long-lasting central cholinergic deficits, potentially explaining the neurological and neuropsychological symptoms presented by some Gulf War veterans. In undertaking to replicate these results in the Long-Evans rat, no evidence of a stress-potentiated central effect of PB, administered at doses up 5.0 mg/kg ip, was found. Three stress protocols were used: restraint, forced swim, or a combined restraint/forced swim. Wistar rats were also tested in some of the protocols to ensure that the results were generalizable across rat strains, and plasma corticosterone levels were measured to test the effectiveness of the stressors employed. In contrast to the previously reported findings in the mouse, stress significantly reduced the entry of PB into rat brain, as measured by reduced inhibition of AChE activity: a 12.5% reduction in whole brain AChE activity after treatment with 5.0 mg/kg PB under control conditions declined to 9% after stress exposure. It is apparent, therefore, that the interaction between stress and PB requires further study, and previous data should be reassessed before they are used as a basis for interpreting symptoms presented by veterans. (C) 2000 Academic Press.

KW - Acetylcholinesterase

KW - Blood-brain barrier permeability

KW - Corticosterone

KW - Physostigmine hemisulfate

KW - Pyridostigmine bromide

KW - Restraint stress

KW - Swim stress

UR - http://www.scopus.com/inward/record.url?scp=0034657512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034657512&partnerID=8YFLogxK

U2 - 10.1006/taap.2000.8931

DO - 10.1006/taap.2000.8931

M3 - Article

VL - 165

SP - 99

EP - 105

JO - Toxicology and Applied Pharmacology

JF - Toxicology and Applied Pharmacology

SN - 0041-008X

IS - 1

ER -